Kappa Bioscience

Kappa Bioscience AS specializes in the development and production of vitamin K2, specifically menaquinone-7 (MK-7), which is marketed under the K2VITAL brand. Founded in 2006 and based in Oslo, Norway, the company offers a range of products tailored for the food supplement and fortified food markets, including microencapsulated DELTA for enhanced stability in mineral formulations. Kappa Bioscience has pioneered the synthesis of all-trans MK-7, ensuring high purity and a reliable supply chain, which facilitates broader consumer adoption. Its products are distributed globally, particularly in Norway and the United States, and are designed to support bone, joint, and cardiovascular health. Kappa Ingredients GmbH, a wholly owned division of Kappa Bioscience, oversees the global sales of K2VITAL and related products, effectively serving nutritional supplement companies and distributors worldwide.